BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is under the NASDAQ ticker symbol BSGM and is subject to market conditions.
Proceeds from the offering will be used for purchasing gold bullion, working capital, and general corporate purposes.
Offering Details
Shares of common stock (or pre-funded warrants) offered through underwritten public offering by BioSig Technologies, Inc.
Underwriters
Clear Street and Needham & Company are joint book-running managers for the offering.
Registration Statement
Offering made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
Prospectus Information
Interested parties should read the preliminary prospectus supplement and accompanying base prospectus before investing.
- BioSig's financial position is expected to strengthen through the public offering.
- Potential increase in liquidity and capital resources for BioSig Technologies, Inc.
BioSig Technologies Inc.'s announcement of the public offering marks a strategic move towards funding key initiatives. The company's focus on gold investment and corporate development is highlighted through this offering.